Average body weight lost at highest dose over 72 weeks Weeks until patients notice significant appetite reduction Of patients lost at least 5% body weight vs 35% on placebo Of patients lost 20% or more of body weight at highest dose *Source: SURMOUNT-1 clinical trial data
Track your progress with 'before and after' comparisons and utilize the measurement tracker to witness tangible results
In TRIUMPH-1, full average weight loss outcomes were reached at 80 weeks (just over 18 months), with continued reductions seen in some patients at 104 weeks
David Kellner, MD: GLP-1 stands for glucagon-like peptide-1, which is a complicated sounding name, but basically it's a hormone that your body naturally releases after you eat
Impact on Weight Loss While both medications offer significant weight loss benefits, studies have shown that Tirzepatide often leads to greater weight reduction than Semaglutide
B12 supports red blood cell production, nerve health, and energy metabolism, which can make the treatment more tolerable and improve overall well-being